This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn.
Outcomes assessed in the review
The authors reported that a systematic review was carried out. The following parameters were used in the model: the prevalence rate of silicosis, the incidence rate of silicosis, the case-fatality rates, the background mortality rates, and the reduction in silica exposure when using selected interventions (wet method, LEV, TPV, and training and PPE).
Study designs and other criteria for inclusion in the review
No study designs and further criteria were reported in the review. The authors reported only that they had used data from published and unpublished literature.
Sources searched to identify primary studies
Not reported.
Criteria used to ensure the validity of primary studies
Methods used to judge relevance and validity, and for extracting data
Number of primary studies included
Overall, 18 publications provided effectiveness data.
Methods of combining primary studies
Investigation of differences between primary studies
It was unclear whether the authors investigated differences between the primary studies.
Results of the review
For the construction industry, the estimated reduction in silica exposure was 86% with the wet method, 85% with the LEV method, and 20% with the training and PPE method.
For the minerals processing industry, the reduction in silica exposure was 79% with the LEV method, 70% with the TPV method, and 50% with the training and PPE method.
For the manufacturing industry (iron and steel foundries, glass, pottery), the estimated reduction in silica exposure was 80% with the wet method, 70% with the LEV method, and 40% with the training and PPE method.
The proportions of American and Chinese populations with current exposure to silica were reported by age group and gender.
Methods used to derive estimates of effectiveness
Some estimates of effectiveness were not derived from the literature. These were based on assumptions and expert opinion, derived through personal communication with individuals.
Estimates of effectiveness and key assumptions
Normal or current exposure to silica (measured as time-weighted average concentrations for an 8-hour period) was estimated to be 2.4 mg/m3 for the task of dry cutting masonry with a portable "chop saw". The exposure was reduced to 0.055 mg/m3 when wet cutting masonry with a stationary wet saw. Thus, the intervention resulted in a 98% reduction in silica exposure.
Normal or current exposure to silica was estimated to be 2.84 mg/m3 for the task of mortar grinding. The exposure was reduced to 0.059 mg/m3 when using LEV. Thus, the intervention resulted in a 98% reduction in silica exposure.
Both estimates were derived through personal communication with an individual at the Center for the Protection of Workers' Rights.
Owing to the lack of appropriate data, the analysis was also based on authors' assumption that interventions (e.g. wet method, LEV, and training and PPE) that are mainly functional in the construction and mineral processing industries would also be suitable for the manufacturing sector, thus producing similar results.
It was also assumed that within a given economic sub-sector, male and female employees are subject to the same probability of exposure, as are young and old employees.
With regards to the training and PPE intervention, it was assumed that there was full compliance with training instructions on behalf of the workers.
Measure of benefits used in the economic analysis
The authors used healthy life-years gained as the measure of benefit. This was based on World Health Organization's definition of Healthy Years Equivalent (i.e. "indicator of the time lived with a disability and the time lost due to premature mortality"). Premature mortality was estimated using standard expected years of life lost derived from model life tables. Loss of physical capacity was estimated using disability weights derived from the literature.
Direct costs
EC intervention costs were included in the analysis and were reported as summary costs. The authors reported that such costs were estimated by taking the weighted average of the different elements of EC costs (e.g. wet cutting equipment for construction workers, TPV, dust control equipment and so on for mineral processing workers). In terms of the EC costs, all aspects of costs related to equipment and capital costs. Further costs included in the analysis were for PPE (i.e. half-FR, full-FR, DMF and CM). Twenty per cent of these costs 20% were assigned to wage costs and 80% comprised equipment or capital costs. Although some unit costs of some cost components were reported, the costs and the quantities were not reported separately as the costs were reported as summary costs. All costs were reported for the two sub-regions (AMROA and WPROB1). The time horizon of the economic analysis was 10 years and all costs were appropriately discounted. The price year was not explicitly reported.
Statistical analysis of costs
The costs were treated deterministically.
Indirect Costs
The indirect costs were not included in the analysis.
Currency
US dollars ($). Currency conversions were not reported.
Sensitivity analysis
No sensitivity analysis was carried out.
Estimated benefits used in the economic analysis
In the AMROA sub-region, 2,880,119 healthy life-years were gained when using ECs, 1,654,601 when using CM, 2,880,119 when using DMF, 2,880,119 when using half-FR, and 3,495,298 when using full-FR.
In the WPROB1 sub-region, 1,184,154 healthy life-years were gained when using ECs, 585,740 when using CM, 1,184,154 when using DMF, 1,184,154 when using half-FR, and 1,498,169 when using full-FR.
Cost results
In the AMROA sub-region, the total costs amounted to $304,988,924 for ECs, $183,726,737 for CM, $551,183,877 for DMF, $863,523,627 for half-FR, and $10,656,25716 for full-FR.
In the WPROB1 sub-region, the total costs amounted to $129,483,316 for ECs, $68,641,179 for CM, $205,925,160 for DMF, $32,261,6913 for half-FR, and $398,123,664 for full-FR.
Synthesis of costs and benefits
In the AMROA sub-region, the average cost per healthy year gained was $105.89 when using ECs, $111.04 when using CM, $191.38 when using DMF, $299.82 when using half-FR, and $304.87 when using full-FR.
In the WPROB1 sub-region, the average cost per healthy year gained was $109.35 when using ECs, $117.19 when using CM, $173.90 when using DMF, $272.45 when using half-FR, and $265.74 when using full-FR.
